A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

Clinical trial NCT05336409 · TERMINATED

Trial details

NCT number: NCT05336409
Sponsor: Century Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

R/R CD19-Positive B-Cell Malignancies Indolent Non-Hodgkin Lymphoma Aggressive Non-Hodgkin Lymphoma

Start date: 2023-01-24
Primary completion: 2025-07-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.